Monoclonal antibodies for the treatment of Graves’ ophthalmopathy: A systematic review and meta-analysis

PURPOSE: The traditional standard of care for Graves’ ophthalmopathy (GO) is glucocorticoid therapy, which is associated with many long-term side effects. The aim of this systematic review and meta-analysis was to compare the traditional therapy to novel monoclonal antibodies (e.g. rituximab [RTX],...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatani, Wed A., Hamdan, Dalia M., Taher, Nada O., Alsharef, Jawaher F., Aldubi, Riyam M., Alwagdani, Alhanouf M., Alhothali, Taif N., Khan, Zia U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365244/
https://www.ncbi.nlm.nih.gov/pubmed/37492211
http://dx.doi.org/10.4103/sjopt.sjopt_176_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365244/
https://www.ncbi.nlm.nih.gov/pubmed/37492211
http://dx.doi.org/10.4103/sjopt.sjopt_176_22

Ejemplares similares